MedTrace Logo

PUER ("Previously Unrecognized Emerging Risks") Life Clinical Study (PUER) in Ages 6 Through 18

NCT06802029 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2025-08-07

No results posted yet for this study

Summary

The goal of this observational study is to learn about changes in health in children that develop over time that may impact overall health and a healthy lifespan. The main questions it aims to answer are:

* What are the changes in health that impact overall health and lifespan in children; and
* What test(s) are best at finding changes in health in children?

Conditions

  • Aging

Interventions

GENETIC

Whole Genome Sequencing Analysis

Laboratory blood analysis

Sponsors & Collaborators

  • Puer Research, LLC

    lead NETWORK

Principal Investigators

  • Szilard Voros, MD · Principal Investigator

Eligibility

Min Age
6 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-01
Primary Completion
2029-12-31
Completion
2030-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06802029 on ClinicalTrials.gov